( September 8, 2026) -- The Federal Trade Commission has sued lifestyle pharmaceutical marketer Hims & Hers on multiple charges, most involving its negative-option subscriptions. These charges seem valid, but the consumer harm is limited, raising the question of why this marginal case is being so tenaciously litigated by both sides....